MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$12,606,904
(2.84%↑ Y/Y)
Interest income, net
$652,086
(-49.42%↓ Y/Y)
Other income
$77,500
Net loss
-$12,599,569
(2.77%↑ Y/Y)
Foreign currency
translation
-$7,335
(54.46%↑ Y/Y)
Total other income
$634,267
(-53.40%↓ Y/Y)
Foreign currency (loss)
gain
-$95,319
(-232.76%↓ Y/Y)
Loss from operations
-$13,233,836
(7.58%↑ Y/Y)
Grant revenue
$285,759
(-80.98%↓ Y/Y)
Total operating
expenses
$13,519,595
(-14.55%↓ Y/Y)
Research and development
$7,043,035
(-24.78%↓ Y/Y)
General and
administrative
$6,476,560
(0.28%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Aprea Therapeutics, Inc. (APRE)
Aprea Therapeutics, Inc. (APRE)